PI Industries
PI Industries
Chemicals F&OKey Fundamentals
SmallcapPesticides & AgrochemicalsChemicalsTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
3- The company has delivered a poor sales growth of 7.96% over past five years.
- Debtor days have increased from 65.4 to 87.6 days.
- Working capital days have increased from 78.5 days to 120 days
Growth Rate
AI Analysis — Bull vs Bear
P I Industries Ltd trades at a market cap of ₹35,265 Cr with a P/E of 30.7x. The company is virtually debt-free but faces near-term headwinds with TTM sales declining 17% and TTM profit declining 33%, while longer-term 10-year compounded sales and profit growth stand at 12% and 14% respectively.
- Company is almost debt-free, providing financial flexibility and low interest burden in a capital-intensive chemicals sector
- 10-year compounded sales CAGR of 12% demonstrates a sustained long-term revenue growth track record
- 10-year compounded profit CAGR of 14% indicates profit growth has historically outpaced revenue growth, suggesting operating leverage
- 10-year average ROE of 17% reflects consistent and healthy return generation on shareholder equity over a long period
- 5-year compounded profit CAGR of 10% remains in double digits despite recent slowdown, showing medium-term earnings resilience
- Price-to-book ratio of 3.19x is relatively moderate for a debt-free specialty chemicals company, implying the balance sheet carries tangible value
- Dividend yield of 0.63% provides a modest income floor, supported by the company's debt-free status and historical profitability
- TTM sales have declined 17%, signalling a sharp near-term revenue contraction that breaks the longer-term growth trend
- TTM profit has declined 33%, nearly double the pace of revenue decline, indicating margin compression alongside falling sales
- Stock price CAGR of -37% over 1 year reflects significant market repricing and erosion of investor confidence
- Last-year ROE has dropped to 11% from a 5-year average of 16% and 10-year average of 17%, indicating deteriorating capital efficiency
- Debtor days have increased from 65.4 to 87.6 days, suggesting slower collections and potential stress in receivables quality
- Working capital days have ballooned from 78.5 to 120 days, tying up significantly more capital in operations and pressuring cash flows
- 3-year compounded sales CAGR of just 1% and 3-year profit CAGR of -1% show the growth slowdown is not merely a one-quarter blip but a multi-year trend
- P/E of 30.7x remains elevated relative to the earnings decline trajectory — if profits do not recover, the current multiple may prove unsustainable
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Investor meetings in Mumbai scheduled Aug 31
PI Industries scheduled one-on-one investor meetings in Mumbai on Sep 3, 9, and 10, 2026 with Fortitude Fund Management, Aberdeen, and Kotak Mutual Fund.
- Virtual investor meet Aug 31 Aug 26
PI Industries scheduled a virtual one-on-one investor meet on Aug 31, 2026 with ITUS Capital. Filing confirmed no UPSI will be shared.
TL;DR: Limited news flow for PI Industries in this period, with only routine investor meeting disclosures. No operational, financial, or sector-specific catalysts emerged. The active engagement with institutional investors like Aberdeen, Kotak MF, and ITUS Capital suggests sustained buy-side interest. Watch for any guidance or sentiment shifts that may surface from these interactions in early September 2026.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,910 | 2,117 | 1,898 | 1,741 | 2,069 | 2,221 | 1,901 | 1,787 | 1,900 | 1,872 | 1,376 | 1,565 | 1,702 |
| Expenses | 1,443 | 1,566 | 1,344 | 1,299 | 1,486 | 1,593 | 1,389 | 1,332 | 1,381 | 1,331 | 1,073 | 1,228 | 1,335 |
| Operating Profit | 468 | 551 | 554 | 442 | 583 | 628 | 512 | 456 | 519 | 541 | 302 | 337 | 367 |
| OPM % | 24% | 26% | 29% | 25% | 28% | 28% | 27% | 25% | 27% | 29% | 22% | 22% | 22% |
| Other Income | 52 | 49 | 58 | 60 | 75 | 123 | 76 | 75 | 89 | 85 | 172 | 74 | 66 |
| Interest | 4 | 8 | 7 | 11 | 8 | 8 | 8 | 8 | 4 | 3 | 6 | 4 | 8 |
| Depreciation | 70 | 80 | 78 | 80 | 83 | 80 | 99 | 90 | 96 | 98 | 105 | 107 | 104 |
| PBT | 445 | 512 | 526 | 411 | 566 | 663 | 481 | 432 | 507 | 525 | 363 | 300 | 322 |
| Tax % | 14% | 6% | 15% | 10% | 21% | 23% | 22% | 24% | 21% | 22% | 14% | 33% | 24% |
| Net Profit | 383 | 480 | 449 | 370 | 449 | 508 | 373 | 330 | 400 | 409 | 311 | 200 | 244 |
| EPS in Rs | 25.24 | 31.67 | 29.57 | 24.35 | 29.58 | 33.5 | 24.57 | 21.78 | 26.36 | 26.98 | 20.52 | 13.2 | 16.1 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,940 | 2,096 | 2,277 | 2,277 | 2,841 | 3,366 | 4,577 | 5,300 | 6,492 | 7,666 | 7,978 | 6,714 | 6,516 |
| Expenses | 1,558 | 1,661 | 1,722 | 1,781 | 2,261 | 2,647 | 3,559 | 4,154 | 4,948 | 5,636 | 5,772 | 4,982 | 4,968 |
| Operating Profit | 382 | 435 | 555 | 496 | 580 | 720 | 1,018 | 1,146 | 1,544 | 2,030 | 2,206 | 1,732 | 1,548 |
| OPM % | 20% | 21% | 24% | 22% | 20% | 21% | 22% | 22% | 24% | 26% | 28% | 26% | 24% |
| Other Income | 35 | 34 | 36 | 60 | 58 | 50 | 129 | 105 | 166 | 216 | 345 | 414 | 397 |
| Interest | 12 | 12 | 9 | 7 | 7 | 19 | 34 | 16 | 39 | 44 | 56 | 43 | 20 |
| Depreciation | 50 | 54 | 73 | 83 | 93 | 137 | 175 | 202 | 226 | 308 | 352 | 407 | 414 |
| PBT | 355 | 403 | 510 | 466 | 538 | 614 | 938 | 1,033 | 1,444 | 1,895 | 2,142 | 1,696 | 1,510 |
| Tax % | 31% | 23% | 10% | 21% | 24% | 26% | 21% | 18% | 15% | 11% | 22% | 22% | — |
| Net Profit | 246 | 312 | 459 | 368 | 410 | 457 | 738 | 844 | 1,230 | 1,682 | 1,660 | 1,321 | 1,165 |
| EPS in Rs | 18 | 22.72 | 33.39 | 26.66 | 29.72 | 33.06 | 48.66 | 55.62 | 81.04 | 111 | 109 | 87.06 | 76.8 |
| Div. Payout % | 14% | 14% | 12% | 15% | 13% | 12% | 10% | 11% | 12% | 14% | 15% | 17% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 14 | 14 | 14 | 14 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 883 | 1,157 | 1,613 | 1,911 | 2,272 | 2,605 | 5,327 | 6,105 | 7,183 | 8,716 | 10,142 | 11,215 |
| Borrowings | 115 | 151 | 120 | 83 | 49 | 519 | 373 | 316 | 46 | 191 | 184 | 342 |
| Other Liabilities | 622 | 626 | 554 | 618 | 820 | 1,087 | 1,287 | 1,354 | 1,235 | 1,822 | 1,908 | 1,832 |
| Total Liabilities | 1,633 | 1,949 | 2,301 | 2,626 | 3,155 | 4,225 | 7,002 | 7,791 | 8,480 | 10,744 | 12,249 | 13,405 |
| Fixed Assets | 533 | 874 | 945 | 998 | 1,186 | 1,858 | 2,138 | 2,452 | 2,606 | 3,528 | 4,209 | 4,620 |
| CWIP | 133 | 71 | 77 | 90 | 183 | 271 | 288 | 114 | 132 | 278 | 550 | 1,030 |
| Investments | 1 | 0 | 83 | 161 | 129 | 150 | 872 | 900 | 1,016 | 1,336 | 1,531 | 1,360 |
| Other Assets | 967 | 1,003 | 1,196 | 1,378 | 1,657 | 1,946 | 3,704 | 4,325 | 4,726 | 5,601 | 5,959 | 6,395 |
| Total Assets | 1,633 | 1,949 | 2,301 | 2,626 | 3,155 | 4,225 | 7,002 | 7,791 | 8,480 | 10,744 | 12,249 | 13,405 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 184 | 367 | 339 | 319 | 391 | 698 | 725 | 529 | 1,501 | 2,036 | 1,413 | 474 |
| Investing | -146 | -303 | -235 | -180 | -322 | -985 | -2,430 | -110 | -496 | -1,800 | -1,421 | -612 |
| Financing | -53 | -48 | -53 | -106 | -125 | 350 | 1,690 | -177 | -483 | -222 | -286 | -171 |
| Net Cash Flow | -15 | 16 | 50 | 33 | -56 | 63 | -15 | 241 | 522 | 14 | -294 | -309 |
| Free Cash Flow | 16 | 48 | 198 | 150 | 23 | 29 | 287 | 192 | 1,179 | 1,417 | 575 | -632 |
| CFO/OP | 79 | 106 | 83 | 84 | 88 | 112 | 87 | 61 | 114 | 119 | 81 | 48 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 72 | 69 | 68 | 84 | 85 | 70 | 56 | 60 | 43 | 44 | 64 | 88 |
| Inventory Days | 124 | 124 | 136 | 141 | 126 | 158 | 149 | 178 | 144 | 124 | 95 | 157 |
| Days Payable | 116 | 115 | 90 | 115 | 121 | 117 | 113 | 115 | 86 | 119 | 117 | 125 |
| Cash Conversion Cycle | 80 | 78 | 113 | 110 | 90 | 111 | 93 | 122 | 101 | 49 | 42 | 119 |
| Working Capital Days | 43 | 54 | 72 | 89 | 87 | 70 | 72 | 93 | 70 | 48 | 67 | 120 |
| ROCE % | 41% | 36% | 34% | 25% | 25% | 23% | 22% | 17% | 22% | 24% | 23% | 15% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view PI Industries insights
63 extracted metrics + investor summaries across FY07–FY26.
Documents
Frequently Asked Questions about PI Industries
What does P I Industries Ltd do?
Where is P I Industries Ltd (PIIND) listed?
Which sector does P I Industries Ltd belong to?
What is the market capitalisation of P I Industries Ltd?
What is the PE ratio of P I Industries Ltd?
What is the 52-week high and low of P I Industries Ltd?
Does P I Industries Ltd pay dividends?
What is the Return on Equity (ROE) of P I Industries Ltd?
Company Information
PI Industries Ltd is a leading player in the agro-chemicals space having strong presence in both Domestic and Export markets. It has state-of-art facilities in Gujarat having integrated process development teams with in-house engineering capabilities.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/PIIND.md for P I Industries Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.